Search hospitals > Ohio > Akron
Children's Hospital Medical Center of Akron
Claim this profileAkron, Ohio 44308
Global Leader in Leukemia
Global Leader in Tumors
Conducts research for Lymphoblastic Leukemia-Lymphoma
Conducts research for Lymphoma
Conducts research for Brain Tumor
208 reported clinical trials
5 medical researchers
Summary
Children's Hospital Medical Center of Akron is a medical facility located in Akron, Ohio. This center is recognized for care of Leukemia, Tumors, Lymphoblastic Leukemia-Lymphoma, Lymphoma, Brain Tumor and other specialties. Children's Hospital Medical Center of Akron is involved with conducting 208 clinical trials across 395 conditions. There are 5 research doctors associated with this hospital, such as Steven J. Kuerbitz, Erin Wright, Megan Sampson, MD, and Ryan Nofziger, MD.Area of expertise
1Leukemia
Global LeaderPhiladelphia chromosome positive
Stage II
NTRK1 positive
2Tumors
Global LeaderStage I
Stage IV
Stage II
Top PIs
Steven J. KuerbitzChildren's Hospital Medical Center of Akron7 years of reported clinical research
Expert in Tumors
Expert in Brain Tumor
48 reported clinical trials
97 drugs studied
Erin WrightChildren's Hospital Medical Center of Akron4 years of reported clinical research
Expert in Tumors
Expert in Brain Tumor
40 reported clinical trials
93 drugs studied
Megan Sampson, MDAkron Children's Hospital10 years of reported clinical research
Studies Infections
Studies Viral Diseases
3 reported clinical trials
3 drugs studied
Ryan Nofziger, MDChildren's Hospital Medical Center of Akron2 years of reported clinical research
Studies Brain Ischemia
Studies Hypothermia
1 reported clinical trial
1 drug studied
Clinical Trials running at Children's Hospital Medical Center of Akron
Brain Tumor
Osteosarcoma
Germ Cell Tumors
Astrocytoma
Acute Lymphoblastic Leukemia
Acute Leukemia
Rhabdomyosarcoma
Non-Hodgkin's Lymphoma
Retinoblastoma
Lymphoma
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
Selumetinib vs Carboplatin/Vincristine
for Brain Cancer
This phase III trial studies if selumetinib works just as well as the standard treatment with carboplatin/vincristine (CV) for subjects with NF1-associated low grade glioma (LGG), and to see if selumetinib is better than CV in improving vision in subjects with LGG of the optic pathway (vision nerves). Selumetinib is a drug that works by blocking some enzymes that low-grade glioma tumor cells need for their growth. This results in killing tumor cells. Drugs used as chemotherapy, such as carboplatin and vincristine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether selumetinib works better in treating patients with NF1-associated low-grade glioma compared to standard therapy with carboplatin and vincristine.
Recruiting2 awards Phase 328 criteria
Selumetinib + Vinblastine
for Low-Grade Glioma
This phase III trial investigates the best dose of vinblastine in combination with selumetinib and the benefit of adding vinblastine to selumetinib compared to selumetinib alone in treating children and young adults with low-grade glioma (a common type of brain cancer) that has come back after prior treatment (recurrent) or does not respond to therapy (progressive). Selumetinib is a drug that works by blocking a protein that lets tumor cells grow without stopping. Vinblastine blocks cell growth by stopping cell division and may kill cancer cells. Giving selumetinib in combination with vinblastine may work better than selumetinib alone in treating recurrent or progressive low-grade glioma.
Recruiting2 awards Phase 339 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Children's Hospital Medical Center of Akron?
Children's Hospital Medical Center of Akron is a medical facility located in Akron, Ohio. This center is recognized for care of Leukemia, Tumors, Lymphoblastic Leukemia-Lymphoma, Lymphoma, Brain Tumor and other specialties. Children's Hospital Medical Center of Akron is involved with conducting 208 clinical trials across 395 conditions. There are 5 research doctors associated with this hospital, such as Steven J. Kuerbitz, Erin Wright, Megan Sampson, MD, and Ryan Nofziger, MD.